Marijuana Company of America Competitors

Innovative Industrial Properties (NYSE:IIPR) and Marijuana Company of America (OTCMKTS:MCOA) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innovative Industrial Properties and Marijuana Company of America, as provided by MarketBeat.com.

Innovative Industrial Properties presently has a consensus target price of $192.4286, indicating a potential upside of 0.84%. Given Innovative Industrial Properties' higher possible upside, equities analysts plainly believe Innovative Industrial Properties is more favorable than Marijuana Company of America.

Earnings & Valuation

This table compares Innovative Industrial Properties and Marijuana Company of America's revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than Marijuana Company of America.

Insider & Institutional Ownership

74.9% of Innovative Industrial Properties shares are held by institutional investors. 2.9% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Innovative Industrial Properties and Marijuana Company of America's net margins, return on equity and return on assets.

Summary

Innovative Industrial Properties beats Marijuana Company of America on 8 of the 8 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and Marijuana Company of America (OTCMKTS:MCOA) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Earnings and Valuation

This table compares GrowGeneration and Marijuana Company of America's gross revenue, earnings per share and valuation.

GrowGeneration has higher revenue and earnings than Marijuana Company of America.

Institutional and Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares GrowGeneration and Marijuana Company of America's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings for GrowGeneration and Marijuana Company of America, as provided by MarketBeat.

GrowGeneration currently has a consensus price target of $49.5714, suggesting a potential downside of 4.96%. Given GrowGeneration's higher possible upside, research analysts plainly believe GrowGeneration is more favorable than Marijuana Company of America.

Summary

GrowGeneration beats Marijuana Company of America on 8 of the 8 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and Marijuana Company of America (OTCMKTS:MCOA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares 22nd Century Group and Marijuana Company of America's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings for 22nd Century Group and Marijuana Company of America, as provided by MarketBeat.

Earnings and Valuation

This table compares 22nd Century Group and Marijuana Company of America's gross revenue, earnings per share and valuation.

Summary

22nd Century Group beats Marijuana Company of America on 1 of the 1 factors compared between the two stocks.

Marijuana Company of America (OTCMKTS:MCOA) and KushCo (OTCMKTS:KSHB) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Marijuana Company of America and KushCo's net margins, return on equity and return on assets.

Institutional & Insider Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Marijuana Company of America and KushCo, as provided by MarketBeat.

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher possible upside, analysts plainly believe KushCo is more favorable than Marijuana Company of America.

Valuation and Earnings

This table compares Marijuana Company of America and KushCo's gross revenue, earnings per share and valuation.

Marijuana Company of America has higher earnings, but lower revenue than KushCo.

Summary

KushCo beats Marijuana Company of America on 5 of the 8 factors compared between the two stocks.

Marijuana Company of America (OTCMKTS:MCOA) and NSAV (OTCMKTS:NSAV) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

Profitability

This table compares Marijuana Company of America and NSAV's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings for Marijuana Company of America and NSAV, as reported by MarketBeat.

Earnings and Valuation

This table compares Marijuana Company of America and NSAV's top-line revenue, earnings per share and valuation.

Marijuana Company of America (OTCMKTS:MCOA) and Terra Tech (OTCMKTS:TRTC) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Marijuana Company of America and Terra Tech's revenue, earnings per share (EPS) and valuation.

Marijuana Company of America has higher earnings, but lower revenue than Terra Tech.

Insider and Institutional Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Marijuana Company of America and Terra Tech's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current recommendations and price targets for Marijuana Company of America and Terra Tech, as reported by MarketBeat.com.